Sens. Chuck Grassley (R-Iowa) and Patrick Leahy (D-Vt.) reintroduced the CREATES Act, S. 974, in an effort to close regulatory loopholes at the Food and Drug Administration (FDA) that limit competition in the emerging market for biosimilars. Sen. Mike Lee and all of the other cosponsors of last year’s bill have returned as cosponsors. Rep. Tom Marino also introduced this bill in the House of Representatives on April 27th.

It hasn’t taken very long for Congress to realize that the burdensome regulations of net neutrality are impeding American innovation. Now, they just need to start peeling them back.